Management of Chronic Problems
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Meaning of Different Forms of Structural Myocardial Injury, Immune Response and Timing of Infarct Necrosis and Cardiac Repair
CORE Metadata, citation and similar papers at core.ac.uk Provided by Archivio della ricerca- Università di Roma La Sapienza Send Orders for Reprints to [email protected] 6 Current Vascular Pharmacology, 2015, 13, 6-19 The Meaning of Different Forms of Structural Myocardial Injury, Immune Response and Timing of Infarct Necrosis and Cardiac Repair Emanuela Turillazzi1*, Cristoforo Pomara1, Stefania Bello1, Margherita Neri1, Irene Riezzo1 and Vittorio Fineschi2 1Institute of Legal Medicine, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy; 2Department of Anatomical, Histological, Forensic and Orthopaedic Sciences, Sapienza Uni- versity of Rome, Rome, Italy Abstract: Although a decline in the all-cause and cardiac mortality rates following myocardial infarction (MI) during the past 3 decades has been reported, MI is a major cause of death and disability worldwide. From a pathological point of view MI consists in a particular myocardial cell death due to prolonged ischemia. After the onset of myocardial ischemia, cell death is not immediate, but takes a finite period of time to develop. Once complete myocytes’ necrosis has occurred, a process leading to a healed infarction takes place. In fact, MI is a dynamic proc- ess that begins with the transition from reversible to irreversible ischemic injury and culminates in the replacement of dead myocardium by a fibrous scar. The pathobiological mechanisms underlying this process are very complex, involving an in- flammatory response by several pathways, and pose a major challenge to ability to improve our knowledge. An improved un- derstanding of the pathobiology of cardiac repair after MI and further studies of its underlying mechanisms provide avenues for the development of future strategies directed toward the identification of novel therapies. -
Alcohol-Medication Interactions: the Acetaldehyde Syndrome
arm Ph ac f ov l o i a g n il r a n u c o e J Journal of Pharmacovigilance Borja-Oliveira, J Pharmacovigilance 2014, 2:5 ISSN: 2329-6887 DOI: 10.4172/2329-6887.1000145 Review Article Open Access Alcohol-Medication Interactions: The Acetaldehyde Syndrome Caroline R Borja-Oliveira* University of São Paulo, School of Arts, Sciences and Humanities, São Paulo 03828-000, Brazil *Corresponding author: Caroline R Borja-Oliveira, University of São Paulo, School of Arts, Sciences and Humanities, Av. Arlindo Bettio, 1000, Ermelino Matarazzo, São Paulo 03828-000, Brazil, Tel: +55-11-30911027; E-mail: [email protected] Received date: August 21, 2014, Accepted date: September 11, 2014, Published date: September 20, 2014 Copyright: © 2014 Borja-Oliveira CR. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Medications that inhibit aldehyde dehydrogenase when coadministered with alcohol produce accumulation of acetaldehyde. Acetaldehyde toxic effects are characterized by facial flushing, nausea, vomiting, tachycardia and hypotension, symptoms known as acetaldehyde syndrome, disulfiram-like reactions or antabuse effects. Severe and even fatal outcomes are reported. Besides the aversive drugs used in alcohol dependence disulfiram and cyanamide (carbimide), several other pharmaceutical agents are known to produce alcohol intolerance, such as certain anti-infectives, as cephalosporins, nitroimidazoles and furazolidone, dermatological preparations, as tacrolimus and pimecrolimus, as well as chlorpropamide and nilutamide. The reactions are also observed in some individuals after the simultaneous use of products containing alcohol and disulfiram-like reactions inducers. -
SAMPLE REPORT - STANDARD 150 We Hope That the Test Result & Report Will Give You Satisfactory Information and That It Enables You, to Make Informed Decisions
Independent Alternative Allergy Specialist Tripenhad, Tripenhad Road, Ferryside, SA17 5RS, Wales/UK 0345 094 3298 | [email protected] | www.allergylink.co.uk Combination Allergy & Intolerance Test Food Intolerance & Substance Sensitivity - Standard 150 - Ref No: AL#438 Name: SAMPLE Date: 15 January 2020 SSAAMMPPLLEE RREEPPOORRTT -- SSTTAANNDDAARRDD 115500 ©©CCooppyyrriigghhtt –– 22000044--22002200 AAlllleerrggyy LLiinnkk Updated: 15.01.2020 www.allergylink.co.uk ©2004-2020 Allergy Link SAMPLE REPORT - STANDARD 150 We hope that the Test Result & Report will give you satisfactory information and that it enables you, to make informed decisions. Content & Reference: Part 1: Test -Table 3 Low Stomach Acid / Enzyme deficiency 18 Part 2: About your Report 4-5 Other possible cause of digestive problems 19-20 About Allergies and Intolerances 5-7 Non-Food Items & Substances Part 3: Allergen’s and Reactions Explained 8 Pet Allergies, House dust mite & Pollen 20-21 Dairy / Lactose 8 Environmental toxins 21 Eggs & Chicken 9 Pesticides and Herbicides 21 Fish, Shellfish, Glucosamine 9 Fluoride (now classified as a neurotoxin) 22 Coffee, Caffeine & Cocoa / Corn 10 Formaldehyde, Chlorine 22 Gluten / Wheat 10 Toiletries / Preservatives MI / MCI 23 Yeast & Moulds 11 Perfume / Fragrance 23 Alcohol - beer, wine 11 Detergents & Fabric conditioners 23-24 Fruit , Citrus fruit 12 Aluminium, Nickel, Teflon, Latex 24 Fructose / FODMAPs | Cellery 12 Vegetables | Nightshades, Tomato 13 Part 4: Beneficial Supplementing of Vitamins & Minerals Soya , bean, products -
Toxicological Profile for Hydrazines. US Department Of
TOXICOLOGICAL PROFILE FOR HYDRAZINES U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Agency for Toxic Substances and Disease Registry September 1997 HYDRAZINES ii DISCLAIMER The use of company or product name(s) is for identification only and does not imply endorsement by the Agency for Toxic Substances and Disease Registry. HYDRAZINES iii UPDATE STATEMENT Toxicological profiles are revised and republished as necessary, but no less than once every three years. For information regarding the update status of previously released profiles, contact ATSDR at: Agency for Toxic Substances and Disease Registry Division of Toxicology/Toxicology Information Branch 1600 Clifton Road NE, E-29 Atlanta, Georgia 30333 HYDRAZINES vii CONTRIBUTORS CHEMICAL MANAGER(S)/AUTHOR(S): Gangadhar Choudhary, Ph.D. ATSDR, Division of Toxicology, Atlanta, GA Hugh IIansen, Ph.D. ATSDR, Division of Toxicology, Atlanta, GA Steve Donkin, Ph.D. Sciences International, Inc., Alexandria, VA Mr. Christopher Kirman Life Systems, Inc., Cleveland, OH THE PROFILE HAS UNDERGONE THE FOLLOWING ATSDR INTERNAL REVIEWS: 1 . Green Border Review. Green Border review assures the consistency with ATSDR policy. 2 . Health Effects Review. The Health Effects Review Committee examines the health effects chapter of each profile for consistency and accuracy in interpreting health effects and classifying end points. 3. Minimal Risk Level Review. The Minimal Risk Level Workgroup considers issues relevant to substance-specific minimal risk levels (MRLs), reviews the health effects database of each profile, and makes recommendations for derivation of MRLs. HYDRAZINES ix PEER REVIEW A peer review panel was assembled for hydrazines. The panel consisted of the following members: 1. Dr. -
January 22, 2013
January 22, 2013 Dear Centers for Medicare & Medicaid Services, I am writing to make a formal request for a new national coverage determination (NCD) for the AlloMap gene expression test that is provided by XDx Expression Diagnostics. I am formally requesting that Medicare choose not to pay a reimbursement for this test, which is an inferior diagnostic test. I will make this case using the publically available evidence below. The AlloMap gene test falls under the benefit category: diagnostic test. The AlloMap gene expression test is designed to identify individuals in need of a heart biopsy to identify acute cellular rejection in a heart transplant population. As such, this test is useful in only a small percentage of Medicare patients. It was approved by the FDA (510(k) Number: k073482) in 2008. From the FDA file k073482, the indications for use are as follows: Indication(s) for use: AlloMap Molecular Expression Testing is an In Vitro Diagnostic Multivariate Index assay (IVDMIA) test service, performed in a single laboratory, assessing the gene expression profile of RNA isolated from peripheral blood mononuclear cells (PBMC). AlloMap Testing is intended to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection (ACR) at the time of testing in conjunction with standard clinical assessment. Indicated for use in heart transplant recipients: • 15 years of age or older • At least 2 months (≥55 days) post-transplant Traditionally, the surveillance of heart transplant recipients for acute cellular rejection (ACR) and antibody mediated rejection (humoral, AMR) has been performed through the interactions of cardiologists and pathologists. -
Allergic and Asthmatic Reactions to Alcoholic Drinks
Addiction Biology (2003) 8, 3 – 11 INVITED REVIEW Allergic and asthmatic reactions to alcoholic drinks HASSAN VALLY1,2,3 & PHILIP J. THOMPSON3 1Communicable Disease Control Branch, Department of Health, Western Australia, 2National Centre of Epidemiology and Population Health, Canberra, ACT, Australia and 3Asthma and Allergy Research Institute Inc. and the Cooperative Research Centre for Asthma, The University of Western Australia, Perth, Western Australia Abstract Alcoholic drinks are capable of triggering a wide range of allergic and allergic-like responses, including rhinitis, itching, facial swelling, headache, cough and asthma. Limited epidemiological data suggests that many individuals are affected and that sensitivities occur to a variety of drinks, including wine, beer and spirits. In surveys of asthmatics, over 40% reported the triggering of allergic or allergic-like symptoms following alcoholic drink consumption and 30 – 35% reported worsening of their asthma. Sensitivity to ethanol itself can play a role in triggering adverse responses, particularly in Asians, which is due mainly to a reduced capacity to metabolize acetaldehyde. In Caucasians, specific non-alcohol components are the main cause of sensitivities to alcoholic drinks. Allergic sensitivities to specific components of beer, spirits and distilled liquors have been described. Wine is clearly the most commonly reported trigger for adverse responses. Sensitivities to wine appear to be due mainly to pharmacological intolerances to specific components, such as biogenic amines and the sulphite additives. Histamine in wine has been associated with the triggering of a wide spectrum of adverse symptoms, including sneezing, rhinitis, itching, flushing, headache and asthma. The sulphite additives in wine have been associated with triggering asthmatic responses. -
Consensus Statement on Endomyocardial Biopsy
Cardiovascular Pathology 21 (2012) 245–274 Original Article 2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology ⁎ ⁎ Ornella Leone a, , John P. Veinot b, , Annalisa Angelini c, Ulrik T. Baandrup d, Cristina Basso c, Gerald Berry e, Patrick Bruneval f, Margaret Burke g, Jagdish Butany h, Fiorella Calabrese c, Giulia d'Amati i, William D. Edwards j, John T. Fallon k, Michael C. Fishbein l, Patrick J. Gallagher m, Marc K. Halushka n, Bruce McManus o, Angela Pucci p, E. René Rodriguez q, Jeffrey E. Saffitz r, Mary N. Sheppard g, Charles Steenbergen n, James R. Stone r, Carmela Tan q, Gaetano Thiene c, Allard C. van der Wal s, Gayle L. Winters r aBologna, Italy bOttawa, Ontario, Canada cPadua, Italy dHjoerring, Denmark eStanford, CA, USA fParis, France gLondon, UK hToronto, Ontario, Canada iRome, Italy jRochester, MN, USA kNew York, NY, USA lLos Angeles, CA, USA mSouthampton, UK nBaltimore, MD, USA oVancouver, BC, Canada pPisa, Italy qCleveland, OH, USA rBoston, MA, USA sAmsterdam, The Netherlands Received 3 August 2011; received in revised form 28 September 2011; accepted 7 October 2011 Abstract The Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology have produced this position paper concerning the current role of endomyocardial biopsy (EMB) for the diagnosis of cardiac diseases and its contribution to patient management, focusing on pathological issues, with these aims: • Determining appropriate EMB use in the context of current diagnostic strategies for cardiac diseases and providing recommendations for its rational utilization ⁎ Corresponding authors. O. Leone is to be contacted at U.O. -
Cardiac Damage After Ischemic Stroke in Diabetic State
REVIEW published: 27 August 2021 doi: 10.3389/fimmu.2021.737170 Cerebral-Cardiac Syndrome and Diabetes: Cardiac Damage After Ischemic Stroke in Diabetic State † † Hong-Bin Lin 1 , Feng-Xian Li 1 , Jin-Yu Zhang 2, Zhi-Jian You 3, Shi-Yuan Xu 1, Wen-Bin Liang 4* and Hong-Fei Zhang 1* Edited by: 1 Department of Anesthesiology, Zhujiang Hospital of Southern Medical University, Guangzhou, China, 2 State Key Laboratory of Junlei Chang, Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China, 3 Guangxi Health Commission Key Shenzhen Institutes of Advanced Laboratory of Clinical Biotechnology, Liuzhou People’s Hospital, Liuzhou, China, 4 University of Ottawa Heart Institute and Technology, Chinese Academy of Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada Sciences (CAS), China Reviewed by: Xinchun Jin, Cerebral-cardiac syndrome (CCS) refers to cardiac dysfunction following varying brain Capital Medical University, China injuries. Ischemic stroke is strongly evidenced to induce CCS characterizing as Xia Li, arrhythmia, myocardial damage, and heart failure. CCS is attributed to be the second Fourth Military Medical University, China leading cause of death in the post-stroke stage; however, the responsible mechanisms *Correspondence: are obscure. Studies indicated the possible mechanisms including insular cortex injury, Wen-Bin Liang autonomic imbalance, catecholamine surge, immune response, and systemic [email protected] fl Hong-Fei Zhang in ammation. Of note, the characteristics of the stroke population reveal a common [email protected] comorbidity with diabetes. The close and causative correlation of diabetes and stroke †These authors have contributed directs the involvement of diabetes in CCS. -
Small Cardiac Lesions Fibrosis of Papillary Muscles and Focal
Small Cardiac Lesions Fibrosis of Papillary Muscles and Focal Cardiac Myocytolysis Arthur STEER, M.D.,1 Teruyuki NAKASHIMA, M.D.,2 Taketsugu KAWASHIMA, M.D.,1 Kelvin K. LEE, M.A.,3 Michael D. DANZIG, M.D.,4* Thomas L. ROBERTSON M.D.,4** and Donald S. DOCK, M.D.4 SUMMARY Three types of small cardiac lesions were described and illustrated: (1) focal type of papillary muscle fibrosis, evidently a healed infarct of the papillary muscle present in 13% of the autopsies, is a histologically characteristic lesion associated with coronary artery disease and healed myocardial infarction, (2) diffuse type of papillary muscle fibrosis, prob- ably an aging change present in almost half of the autopsies, is associated with sclerosis of the arteries in the papillary muscle, is identifiable his- tologically, and apparently is not associated with any cardiac abnormal- ity, and (3) focal cardiac myocytolysis, a unique histologic lesion, usually multifocal without predilection for any area of the heart, is associated with ischemic heart disease, death due to cancer complicated by non- bacterial thrombotic endocarditis and microthrombi in small cardiac arteries as well as with other diseases. Differentiation of the 2 types of papillary muscle fibrosis is important in the study of papillary muscle and mitral valve dysfunction. Focal cardiac myocytolysis may contribute to the fatal extension of myocardial infarcts. From the Radiation Effects Research Foundation Hiroshima and Nagasaki. A Cooperative Research Institute supported by funds from the U.S.A. National Academy of Sciences-National Research Council, Atomic Energy Commission and Environmental Protection Agency and from the Japanese National Institute of Health of the Ministry of Health and Welfare. -
Nevada Edition
Alcohol Daddy® Alcohol Awareness Program Nevada Edition AlcoholDaddy.com 3160 S. Valley View Blvd, Suite 108, Las Vegas, NV 89102 (888) 860-3031 • [email protected] This alcohol awareness training program was developed by food and beverage industry experts, including college hospitality school professors, bartenders, police/narcotics officers, fraud ID experts as well as medical professionals to provide a thorough and comprehensive understanding of alcohol laws and regulations as they affect you in the workplace. The Alcohol Daddy® program is approved and certified by the Nevada Commission on Postsecondary Education and satisfies employment requirements for alcohol awareness training. For more information, visit AlcoholDaddy.com. Our training curriculum was specifically developed with YOU in mind! This program includes simple information, interesting facts, and organized sections to provide you with the knowledge and skills necessary to respond to a variety of alcohol-related situations with confidence. Congratulations on taking the initiative to become a more proactive team member in your establishment and keeping employees and guests safe! Sincerely, Alcohol Daddy® Copyright © 2015. Alcohol Daddy® Program. AlcoholDaddy.com. All rights reserved. TABLE OF CONTENTS SECTION 1 — Program Introduction Lesson 1: Course Overview and Legal Information 1-2 Lesson 2: Alcohol Licensing Regulations 3 Lesson 3: Ethical Responsibilities of the Server/Seller 4 SECTION 2 — Clinical Effects of Alcohol Lesson 1: Introduction to Alcohol 6 Lesson -
An Experimental Analysis of Acquired Impulse Control Among Adult Humans Intolerant to Alcohol
An experimental analysis of acquired impulse control among adult humans intolerant to alcohol Jianxin Wanga, Yulei Raoa, and Daniel E. Houserb,c,1 aSchool of Business, Central South University, Changsha 410083, People’s Republic of China; bDepartment of Economics, George Mason University, Fairfax, VA 22030; and cInterdisciplinary Center for Economic Science, George Mason University, Fairfax, VA 22030 Edited by Roy Baumeister, Florida State University, Tallahassee, FL, and accepted by Editorial Board Member Michael S. Gazzaniga December 22, 2016 (received for review July 9, 2016) The ability to control tempting impulses impacts health, education, leads to systematic differences in the need to practice small acts and general socioeconomic outcomes among people at all ages. of self-control. This paper fills that gap. Consequently, whether and how impulse control develops in adult Our interest is to investigate a key prediction of the strength populations is a topic of enduring interest. Although past research model: repeatedly practicing small acts of self-control leaves a has shed important light on this question using controlled in- person more able to use willpower than another observationally tervention studies, here we take advantage of a natural experiment identical person without this practice. Many experimental tests of in China, where males but not females encounter substantial social this prediction have appeared (17, 18). A typical experiment assigns pressure to consume alcohol. One-third of our sample, all of whom people randomly to practice self-control (or not) for a relatively are Han Chinese, is intolerant to alcohol, whereas the remaining short period (usually days or weeks), and subsequently assesses control sample is observationally identical but alcohol tolerant. -
Guide to Alcoholism and Alcohol-Related Topics on Josiah
1 ALCOHOL AND ADDICTION STUDIES GUIDE TO RESOURCES ON JOSIAH This is a guide to searching Josiah for material on alcohol and alcoholism studies, and also for addiction studies in general. The guide also covers substance abuse, which is the abuse of alcohol, drugs, and other chemical substances collectively. Other than alcoholism, this guide does not cover works on individual addictions such as drug addiction or compulsive gambling. 1. Library of Congress call numbers BJ1596 Twelve-step programs BV4460.5 Church work with alcoholics E98.L7 Indians of North America and alcoholism GT2884-GT2898 Alcoholic beverages (Manners and customs). Drinking customs HD9350-HD9398 Alcoholic beverage industry and trade HE5620.D7 Drunk driving. Drinking and traffic accidents HF5549.5.A4 Alcoholism and employment HJ5021 Illicit distilling. Moonshining HV4997-HV5000 Substance abuse HV5001-HV5722 Alcoholism. Drinking problem. Temperance and temperance reform HV5068-HV5072 Temperance fiction, plays, poems, and essays HV5088-HV5091 Prohibition HV5275-HV5276 Alcoholics Anonymous. General works on care, treatment, and rehabilitation of alcoholics HV5290-HV5296 Temperance reform and reformers (U.S.). Temperance movement (U.S.) K3609.A5 Legal status of alcoholics and intoxicated persons KF3829.A5 Alcoholism and the law (U.S.) KF3901-KF3925 Liquor laws, alcoholic beverage control, prohibition (U.S.) M2198 Temperance songs NC1763.A54 Alcoholism—Caricatures and cartoons P96.A42 Alcoholism and drinking in mass media PN56.D8 Alcoholism and drinking in literature PN1995.9.A45 Alcoholism in motion pictures PN6071 Drinking in literature—Collections PN6231.D7 Alcoholics—Humor. Drinking—Humor QP801.A3 Physiological effect of alcohol RC268.7.A42 Alcohol and cancer RC533 Compulsive behavior. Addictive behavior RC563-RC564.68 Medical aspects of substance abuse and drug abuse RC564.7-RC565.9 Medical aspects of alcoholism RG629.F5 Fetal alcohol syndrome RM256-RM257 Therapeutic use of alcohol and alcoholic beverages RM302 Drug-alcohol interactions TP500-TP617 Manufacturing of alcoholic beverages.